\u00a0<\/div>\n<\/div>\n<\/div>\n<\/div>\n
The sublay procedure is the most widely performed open surgery ventral hernia repair method for large incisional hernias. With this clearance, the T-Line Hernia Mesh is indicated for the reinforcement of soft tissue where weakness exists for the repair of ventral hernias performed via an open onlay or sublay approach in adults.<\/p>\n
Deep Blue’s T-Line mesh design includes novel mesh extensions that provide superior anchor strength designed to prevent mesh fixation failure. T-Line’s design offers the surgeon the ability to provide optimal mesh tension adjustment and many other potential surgical and clinical advantages compared to conventional mesh application.<\/p>\n
“Many hernia surgeons prefer the sublay technique for hernia repair and have been eager to use T-Line for this, so we are thrilled to receive this clearance to enable broader clinical use,” said Dr.\u00a0Howard Levinson<\/span>, Deep Blue’s founder and Chief Medical Officer.<\/p>\n“There are 4\u20135 million abdominal incisions (laparotomies) performed annually in\u00a0the United States<\/span>\u00a0with hernias resulting after approximately 25% of these procedures1<\/sup>. Further, long-term ventral hernia repair failure rates are up to 32% using conventional mesh and 63% with suture repair only, creating a multibillion-dollar clinical cost to the US healthcare system2<\/sup>. Consequently, there are over 400,000 incisional hernia repairs performed each year in\u00a0the United States<\/span>\u00a0making it one of the five most common procedures performed by general surgeons1<\/sup>,” said CEO\u00a0Bill Perry<\/span>. “This expanded clinical indication allows our growing number of clinical sites to address this important \u00a0problem in significantly more patients with T-Line Hernia Mesh.”<\/p>\n\nHarris HW\u00a0Innovations for Incisional Hernia Prevention, J. of Abdom. Wall Surg<\/i>. (2022) 1:10945<\/li>\nBurger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J.\u00a0Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg<\/i>. (2004) Oct;240(4):578-83<\/li>\n<\/ol>\n About Deep Blue Medical Advances:<\/b>\u00a0Established in 2015, Deep Blue Medical Advances is dedicated to addressing the unacceptably high rate of hernia recurrence and providing surgeons a superior surgical experience. Deep Blue Medical is commercializing T-Line\u00ae\u00a0Hernia Mesh and has a portfolio of additional hernia and surgical products in development.<\/p>\n
SOURCE Deep Blue Medical Advances<\/p>\n
<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"
Deep Blue Medical Advances announced today it has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its T-Line\u00ae\u00a0Hernia Mesh for the sublay technique in open hernia surgery. <\/p>\n","protected":false},"author":1119,"featured_media":125,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ncst_custom_author":"","ncst_show_custom_author":false,"ncst_dynamicHeaderBlockName":"","ncst_dynamicHeaderData":"","ncst_content_audit_freq":"","ncst_content_audit_date":"","ncst_content_audit_display":false,"ncst_backToTopFlag":"","footnotes":""},"categories":[9],"tags":[56,122,123,59,47],"class_list":["post-1459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-angel-investing","tag-deep-blue-medical-advances","tag-fda-clearance","tag-north-carolina-startups","tag-wolfpack-investor-network"],"displayCategory":null,"acf":{"ncst_posts_meta_modified_date":null},"yoast_head":"\n
Deep Blue Medical Advances Announces FDA Clearance for Sublay Application in Hernia Surgery, Enabling Broader Use of T-Line Hernia Mesh - Wolfpack Investor Network<\/title>\n \n \n \n \n \n \n \n \n \n \n \n\t \n\t \n\t \n \n \n \n\t \n\t \n\t \n